Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

Abstract Background Immune checkpoint inhibitors have radically changed the landscape of anti-tumor therapies in several malignancies. However the adverse events associated with immune checkpoint blockade in combination with other treatments remains to be thoroughly documented. Here we report the ca...

Full description

Bibliographic Details
Main Authors: Julie Charles, Diane Giovannini, Nicolas Terzi, Carole Schwebel, Nathalie Sturm, Dominique Masson, Marie-Thérèse Leccia, Jean-Yves Cahn, Olivier Manches, Claude-Eric Bulabois, Laurence Chaperot
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Experimental Hematology & Oncology
Subjects:
Hodgkin lymphoma
Nivolumab
PD1
GVHD
Myositis
Allogeneic stem cell transplantation
Online Access:http://link.springer.com/article/10.1186/s40164-019-0132-2

Internet

http://link.springer.com/article/10.1186/s40164-019-0132-2

Similar Items